From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
Authors
Keywords
-
Journal
BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 42, Issue 2, Pages 587-592
Publisher
Portland Press Ltd.
Online
2014-03-20
DOI
10.1042/bst20130229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between caffeine intake and age at onset in Huntington's disease
- (2013) Clémence Simonin et al. NEUROBIOLOGY OF DISEASE
- Adenosine Receptor Antagonists Including Caffeine Alter Fetal Brain Development in Mice
- (2013) C. G. Silva et al. Science Translational Medicine
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
- (2013) T. Wyss-Coray et al. Cold Spring Harbor Perspectives in Medicine
- NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model
- (2012) Sylvie Burnouf et al. AGING CELL
- From A1 to A3 en passant Through A2A Receptors in the Hippocampus: Pharmacological Implications
- (2012) Ana M. Sebastiao et al. CNS & Neurological Disorders-Drug Targets
- Detrimental Effects of Diet-Induced Obesity on Pathology Are Independent of Insulin Resistance in Transgenic Mice
- (2012) A. Leboucher et al. DIABETES
- Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model
- (2012) J. Brouillette et al. JOURNAL OF NEUROSCIENCE
- Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation
- (2012) V L Batalha et al. MOLECULAR PSYCHIATRY
- Caffeine for treatment of Parkinson disease: A randomized controlled trial
- (2012) R. B. Postuma et al. NEUROLOGY
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
- (2012) Valérie Vingtdeux et al. Frontiers in Physiology
- Adenosine and Related Drugs in Brain Diseases: Present and Future in Clinical Trials
- (2011) Luisa V. Lopes et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction
- (2011) Nelson Rebola et al. JOURNAL OF NEUROCHEMISTRY
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
- (2011) Paul Hollingworth et al. NATURE GENETICS
- Epidemiology of Alzheimer disease
- (2011) Christiane Reitz et al. Nature Reviews Neurology
- Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology
- (2011) Karim Belarbi et al. NEUROBIOLOGY OF DISEASE
- Enhancement of LTP in Aged Rats is Dependent on Endogenous BDNF
- (2011) Maria J Diógenes et al. NEUROPSYCHOPHARMACOLOGY
- Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
- (2010) Lars M. Ittner et al. CELL
- Healthy Brain Aging: Role of Cognitive Reserve, Cognitive Stimulation, and Cognitive Exercises
- (2010) Asenath La Rue CLINICS IN GERIATRIC MEDICINE
- Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet
- (2010) Jaya R.P. Prasanthi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Genetic Mechanisms of Coffee Extract Protection in a Caenorhabditis elegans Model of -Amyloid Peptide Toxicity
- (2010) V. Dostal et al. GENETICS
- Nuclear Tau, a Key Player in Neuronal DNA Protection
- (2010) Audrey Sultan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Caffeine Modulates Tau Phosphorylation and Affects Akt Signaling in Postmitotic Neurons
- (2010) Antonio Currais et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Local Glutamate Level Dictates Adenosine A2A Receptor Regulation of Neuroinflammation and Traumatic Brain Injury
- (2010) S. S. Dai et al. JOURNAL OF NEUROSCIENCE
- Decaffeinated Coffee and Nicotine-Free Tobacco Provide Neuroprotection in Drosophila Models of Parkinson's Disease through an NRF2-Dependent Mechanism
- (2010) K. Trinh et al. JOURNAL OF NEUROSCIENCE
- The secretases: enzymes with therapeutic potential in Alzheimer disease
- (2010) Bart De Strooper et al. Nature Reviews Neurology
- Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission
- (2010) Ann Van der Jeugd et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
- (2010) Brian R. Hoover et al. NEURON
- Novel investigational adenosine A2Areceptor antagonists for Parkinson's disease
- (2009) Annalisa Pinna EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by -Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway
- (2009) P. M. Canas et al. JOURNAL OF NEUROSCIENCE
- Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology
- (2009) M. Polydoro et al. JOURNAL OF NEUROSCIENCE
- Adenosine A2A receptor mediates microglial process retraction
- (2009) Anna G Orr et al. NATURE NEUROSCIENCE
- Adenosine A2a receptor induced gliosis via Akt/NF-κB pathway in vitro
- (2009) Rong-Hu Ke et al. NEUROSCIENCE RESEARCH
- Adenosine A2Areceptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms
- (2008) Liqun Yu et al. ANNALS OF NEUROLOGY
- Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions
- (2008) N. Simola et al. CURRENT PHARMACEUTICAL DESIGN
- Biochemistry of Tau in Alzheimer’s disease and related neurological disorders
- (2008) Nicolas Sergeant et al. Expert Review of Proteomics
- Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
- (2008) Giulio Maria Pasinetti et al. JOURNAL OF NEUROCHEMISTRY
- Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801
- (2007) Geanne M.A. Cunha et al. EXPERIMENTAL NEUROLOGY
- Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
- (2007) Reinaldo Naoto Takahashi Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started